•
KZ
KZR
Kezar Life Sciences, Inc. Common Stock
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
45.04M
Volume
24.64K
52W High
$6.65
52W Low
$3.53
Open
$6.16
Prev Close
$6.15
Day Range
6.12 - 6.25
About Kezar Life Sciences, Inc. Common Stock
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Latest News
Kezar Launches Strategic Review As FDA Roadblock Derails Liver Drug Plans
Benzinga•Oct 17
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
Benzinga•Oct 5
Kezar (KZR) Falls 10% on Strategic Update, Reduces Workforce
Zacks Investment Research•Oct 4
Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Benzinga•Sep 21
The economy is about to slow down. That's the time for retail stocks, says Goldman Sachs.
MarketWatch•Sep 21
Top 5 Health Care Stocks That Could Blast Off This Month
Benzinga•Aug 21
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga•Aug 11
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
Benzinga•Aug 11